ACTON, Mass., June 10, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod ® 5 App for iPhone is ...

First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required ...

Insulet recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery capabilities. Over the ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made ...

Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve the Insulet’s Omnipod Horizon Automated ...

Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 ...

Omnipod 5 is currently eligible for people aged two years and above with Type 1 diabetes. The tubeless AID system communicates with a continuous glucose monitor (CGM), proactively correcting for highs ...

EDINBURGH - DexCom , Inc. (NASDAQ:DXCM), a pioneer in real-time continuous glucose monitoring (CGM) technology, has announced the integration of its Dexcom (NASDAQ:DXCM) G6 CGM system with the ...

SAN DIEGO & ACTON, Mass.--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM) and Insulet Corporation (NASDAQ: PODD), have announced a global commercialization agreement to combine current and future Dexcom ...